Alex Tarrabain - Jun 25, 2021 Form 4 Insider Report for CEN BIOTECH INC (CENBF)

Role
Chief Financial Officer, Director
Signature
/s/ Alex Tarrabain
Stock symbol
CENBF
Transactions as of
Jun 25, 2021
Transactions value $
$0
Form type
4
Date filed
6/25/2021, 05:04 PM
Previous filing
Jun 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CENBF Common Stock Award $0 +1M +56.31% $0.00 2.78M Jun 25, 2021 Direct F1
transaction CENBF Common Stock Other $0 +3K +0.11% $0.00 2.78M Jun 16, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1,000,000 shares of common stock of the issuer were granted by the issuer on June 25, 2021, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
F2 3,000 shares of common stock of the issuer were issued to the reporting person on June 16, 2021, as consideration for extending the maturity date of a promissory note dated January 14, 2018.